Valuation AstraZeneca PLC NYSE

Stocks

Real-time Estimate Cboe BZX 15:15:31 2026-09-24 EDT			5-day change	1st Jan Change
165.16 ^USD	+1.12%		+0.27%	+79.85%

12:55am	Nordic stocks in North America, Astra Zeneca fell 1.2%	FW
09-23	Polaris Rx And AstraZeneca Name Polaris Rx Exclusive U.S. Distributor Of AstraZeneca's FluMist® Home Service For Second Consecutive Year	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	182,034	209,442	209,268	203,171	287,813	255,588	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	-11.2%	-	-
Enterprise Value (EV) ¹	206,417	232,365	231,778	227,741	311,187	275,282	267,519	258,776
Change	-	12.57%	-0.25%	-1.74%	36.64%	-11.54%	-2.82%	-3.27%
P/E	1,469x	64.1x	35.4x	29.1x	28.4x	21x	18.3x	15.9x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	4.73x	4.13x	3.57x
PEG	-	0x	0.4x	1.6x	0.6x	1.1x	1.3x	1x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	4.05x	3.81x	3.59x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	4.36x	3.99x	3.64x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	12.4x	11x	9.64x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	13.1x	11.5x	10.1x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	28.7x	20.6x	17.7x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.49%	4.86%	5.65%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.34	3.544	3.655
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	2.03%	2.15%	2.22%
EPS ²	0.08	2.11	3.81	4.5	6.54	7.844	8.987	10.37
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	42.6%	39.4%	35.2%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,166	67,011	71,149
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,193	24,358	26,836
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,092	23,268	25,554
Net income ¹	112	3,288	5,961	7,035	10,225	12,044	13,773	15,801
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	19,694	11,931	3,188
Reference price ²	117.51	135.16	135.02	131.05	185.60	164.79	164.79	164.79
Nbr of stocks (in thousands)	1,549,159	1,549,528	1,549,926	1,550,317	1,550,726	1,551,024	-	-
Announcement Date	2/10/22	2/9/23	2/8/24	2/6/25	2/10/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	32.72x	11.87x	24.12x	0.6%	1,026B
JOHNSON & JOHNSON	29.94x	6.66x	18.64x	2%	649B
ABBVIE INC.	33.52x	7.84x	16.21x	2.59%	468B
ROCHE HOLDING AG	19.75x	4.81x	11.92x	2.76%	352B
NOVARTIS AG	20.12x	5.24x	13.01x	3.05%	271B
ASTRAZENECA PLC	21.01x	4.36x	12.4x	2.03%	256B
AMGEN INC.	25.68x	6.7x	11.94x	2.48%	220B
GILEAD SCIENCES, INC.	-45.78x	6.66x	26.01x	2.17%	188B
NOVO NORDISK A/S	11.29x	4.12x	8.55x	4.45%	170B
Average	16.47x	6.47x	15.87x	2.46%	399.9B
Weighted average by Cap.	23.74x	7.73x	17.86x	1.99%